Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Aug:142 ( Pt 8):2207-12.
doi: 10.1099/13500872-142-8-2207.

The occurrence of carboxymycobactin, the siderophore of pathogenic mycobacteria, as a second extracellular siderophore in Mycobacterium smegmatis

Affiliations
Free article

The occurrence of carboxymycobactin, the siderophore of pathogenic mycobacteria, as a second extracellular siderophore in Mycobacterium smegmatis

C Ratledge et al. Microbiology (Reading). 1996 Aug.
Free article

Abstract

Carboxymycobactin, in which the usual intracellular mycobactin siderophore is modified by possession of a carboxylic acid group, has been isolated as a second extracellular siderophore from culture filtrates of Mycobacterium smegmatis grown under iron-deficient conditions. (The primary siderophore is an exochelin which is a trihydroxamate, pentapeptide derivative). There may be up to 12 similar molecules produced with differing chain lengths that can be recognized by HPLC or HPTLC. The amount of carboxymycobactin is about 20 times higher when cultures are grown with glycerol instead of glucose. Formation is maximal with an initial pH of the medium of about 8.4. The proportion of carboxymycobactin to the total siderophore produced--mainly exochelins--is maximally 10% (usually 10-25 micrograms ml(-1)). Formation of both extracellular siderophores (exochelin and carboxymycobactin) and of the intracellular mycobactin is maximal at the same initial concentration of iron added to the medium, 0.05-0.1 micrograms Fe ml(-1), though exochelin is synthesized 24 h in advance of both carboxymycobactin and mycobactin.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources